Which vaccines will RFK end recommendations for in 2025?

Which vaccines will RFK end recommendations for in 2025?

$591,373 vol

ALL

Market Rules

DTaP-IPV-Hib-HepB

The outcome is No

If the CDC ends its recommendation completely for the DTaP-IPV-Hib-HepB vaccine before Jan 1, 2026, then the market resolves to Yes. Outcome verified from CDC.

Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Criterion.

Timeline and payout

Market openDec 13, 2024 · 10:00am EST

Market closedAfter the outcome occurs

Paid out30 minutes after closing

This market will close and expire early if the event occurs. Otherwise, it closes by Jan 1, 2026 at 2:59am EST.

SeriesKXVACCINERECS

EventKXVACCINERECS-26

MarketKXVACCINERECS-26-DTAPI

Insider trading is prohibited

The following are prohibited from trading this contract:

Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.